On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Brian N. Bundy

ResearcherPublications, citations & collaboration network

Brian N. Bundy is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Brian N. Bundy have?

ScholarIQindexed works

Brian N. Bundy has 166 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Brian N. Bundy have?

ScholarIQcitation count

Brian N. Bundy has 34,015 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Brian N. Bundy?

ScholarIQh-index

Brian N. Bundy has an h-index of 67 in OpenAlex.

What is the i10-index of Brian N. Bundy?

ScholarIQi10-index

Brian N. Bundy has an i10-index of 99 in OpenAlex.

What is the ORCID of Brian N. Bundy?

ScholarIQorcid

The ORCID for Brian N. Bundy is on the source record.

What is the OpenAlex record for Brian N. Bundy?

ScholarIQopenalex

The OpenAlex for Brian N. Bundy is on the source record.

What are the most-cited papers on Brian N. Bundy?

ScholarIQmost cited works
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Peter G. Rose, Brian N. Bundy, E. Blake Watkins, J.T. Thigpen, Günther Deppe, Mitchell Maiman, Daniel L. Clarke‐Pearson, Sam J. Insalaco
New England Journal of Medicine. 19992,684 CitationsOPEN ACCESS
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel, Helen Huang, Rebecca N. Baergen, Shashikant Lele, Larry J. Copeland, Joan L. Walker, Robert A. Burger
New England Journal of Medicine. 20062,636 CitationsOPEN ACCESS
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen
Journal of Clinical Oncology. 20032,059 Citations
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
New England Journal of Medicine. 20191,141 CitationsOPEN ACCESS
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler
The Lancet. 2011608 Citations

Related on ScholarIQ

470M+ articles · free account